MORONI, GABRIELLA
 Distribuzione geografica
Continente #
NA - Nord America 2.917
AS - Asia 1.450
EU - Europa 1.285
SA - Sud America 300
AF - Africa 48
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.008
Nazione #
US - Stati Uniti d'America 2.741
SG - Singapore 561
CN - Cina 309
IT - Italia 302
BR - Brasile 214
DE - Germania 203
RU - Federazione Russa 176
VN - Vietnam 167
HK - Hong Kong 151
CA - Canada 135
IE - Irlanda 132
SE - Svezia 99
AT - Austria 79
FR - Francia 71
GB - Regno Unito 62
IN - India 58
BD - Bangladesh 41
JP - Giappone 34
AR - Argentina 29
MX - Messico 28
UA - Ucraina 27
ES - Italia 25
TR - Turchia 22
FI - Finlandia 19
DK - Danimarca 18
ZA - Sudafrica 17
GR - Grecia 16
IQ - Iraq 16
PK - Pakistan 15
CO - Colombia 14
PL - Polonia 11
EC - Ecuador 10
EG - Egitto 10
ID - Indonesia 10
NL - Olanda 10
SA - Arabia Saudita 10
KR - Corea 9
PT - Portogallo 9
VE - Venezuela 9
CL - Cile 8
MY - Malesia 7
AU - Australia 6
MA - Marocco 6
PE - Perù 6
UZ - Uzbekistan 6
AZ - Azerbaigian 5
NO - Norvegia 5
PA - Panama 5
PH - Filippine 5
UY - Uruguay 5
JO - Giordania 4
LT - Lituania 4
NP - Nepal 4
PY - Paraguay 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CZ - Repubblica Ceca 3
TN - Tunisia 3
BG - Bulgaria 2
CH - Svizzera 2
CY - Cipro 2
JM - Giamaica 2
KE - Kenya 2
NG - Nigeria 2
AM - Armenia 1
AO - Angola 1
BE - Belgio 1
BH - Bahrain 1
CM - Camerun 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MR - Mauritania 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SC - Seychelles 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.008
Città #
Ann Arbor 520
Singapore 378
Ashburn 296
San Jose 226
Fairfield 154
Hong Kong 148
Frankfurt am Main 147
Dublin 131
Chandler 126
Wilmington 110
Toronto 106
New York 75
Vienna 71
Milan 70
Woodbridge 67
Houston 66
Seattle 65
Los Angeles 64
Beijing 60
Cambridge 58
Dallas 58
Santa Clara 58
Ho Chi Minh City 52
Chicago 41
Dearborn 41
Princeton 40
Hanoi 35
The Dalles 32
Shanghai 29
Guangzhou 25
Munich 25
Nanjing 23
São Paulo 22
Buffalo 20
Altamura 19
Lawrence 17
Lauterbourg 16
San Diego 15
London 14
Dong Ket 13
Rome 13
Moscow 12
Orem 12
Brooklyn 11
Jacksonville 11
Tokyo 11
Athens 10
Hefei 10
Boardman 9
Montreal 9
Turku 9
Warsaw 9
Da Nang 8
Denver 8
Dundee 8
Hải Dương 8
Lissone 8
Mexico City 8
Phoenix 8
Seoul 8
Buenos Aires 7
Chennai 7
Curitiba 7
Helsinki 7
Jakarta 7
Johannesburg 7
Olbia 7
Ottawa 7
Philadelphia 7
Turin 7
Andover 6
Atlanta 6
Barcelona 6
Bogotá 6
Boston 6
Campinas 6
Hangzhou 6
Karachi 6
Paris 6
Porto Alegre 6
Rio de Janeiro 6
Washington 6
Ankara 5
Arlington 5
Baku 5
Belo Horizonte 5
Calgary 5
Columbus 5
Council Bluffs 5
Dhaka 5
Edmonton 5
Kolkata 5
Manchester 5
Mumbai 5
Nantes 5
Nuremberg 5
Oslo 5
Panama City 5
Poplar 5
Pune 5
Totale 3.955
Nome #
Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis 707
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 387
Kidney Involvement 376
Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient) 355
Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients 347
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis 329
Neutrophil Extracellular Traps (NETs) profiles in patients with incident SLE and lupus nephritis 328
Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome) 298
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis 282
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study 273
FP165 Slowly progressive anca-associated glomerulonephritis: a multicentre study 248
The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study 241
CLINICAL FEATURES AND RENAL PROGNOSIS IN LUPUS NEPHRITIS PATIENTS UNDERGOING A REPEATED BIOPSY: RESULTS OF 103 RE-BIOPSIES IN 438 PATIENTS 240
RITUXIMAB AS MAINTENANCE THERAPY FOR SYSTEMIC LUPUS ERYTHEMATOSUS 229
Milder clinical presentation of lupus nephritis and improved renal survival during the last 50 years: a multicentric study 229
Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis 229
Evidence for charge-based mimicry in anti dsDNA antibody generation 228
Slowly progressive anti-neutrophil cytoplasmic antibody-associated renal vasculitis: clinico-pathological characterization and outcome 218
Prognostic Factors and Long-Term Outcome with ANCA-Associated Kidney Vasculitis in Childhood 209
P0346THE EFFECTS OF RITUXIMAB MAINTENANCE THERAPY ON LUPUS NEPHRITIS 197
Clinical and peculiar immunological manifestations of SARS-CoV-2 infection in systemic lupus erythematosus patients 180
Totale 6.130
Categoria #
all - tutte 19.286
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.286


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022360 41 77 41 30 16 28 14 13 12 20 28 40
2022/2023561 39 175 81 45 22 83 14 26 48 5 13 10
2023/2024436 14 12 23 31 51 115 68 10 42 12 8 50
2024/20251.098 50 107 105 43 83 47 101 19 134 178 105 126
2025/20262.343 283 80 178 281 298 131 343 92 158 178 158 163
2026/202714 14 0 0 0 0 0 0 0 0 0 0 0
Totale 6.130